The Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, the world's first comprehensive center aimed at advancing research, treatment, and prevention of BRCA-related cancers, is honoring Alan D. D'Andrea, MD, of Dana-Farber Cancer Institute with the 2025 BRCA Impact Award.
Individuals with mutations in the BRCA1 and BRCA2 genes are at an increased risk of breast, ovarian, pancreatic, and prostate cancers. The award was created to recognize a national leader in the field of cancer genetics and will be presented at the 14th annual Basser Center Scientific Symposium, taking place May 12-13, 2026.
"The BRCA Impact Award honors investigators whose insight and influence have profoundly advanced the science of cancer genetics," said Susan M. Domchek, MD, executive director of the Basser Center for BRCA. "We are pleased to recognize Dr. D'Andrea, whose work continues to propel discovery that improves care for countless individuals and families."
